Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
123 Leser
Artikel bewerten:
(0)

The Weight Loss Solutions Offered by Dr. Feiz Affect Patients at a Genetic Level

LOS ANGELES, May 3, 2013 /PRNewswire/ -- Michael Feiz, M.D., FACS is renowned throughout Southern California for performing life-changing weight loss procedures such as FDA compliant lap band surgery. One of the most effective procedures of Dr. Feiz, the sleeve gastrectomy, helps patients lose weight by removing large portions of the fundus, which contains the ghrelin hormone that causes the hunger cravings that often make weight loss so difficult. However, in addition to their success in promoting weight loss, new evidence shows that many of these procedures are leading to other major health benefits as well.

More research will be needed before it is known precisely why gastric bypass surgery has been found to induce early remission of type 2 diabetes in the vast majority of patients, according to a report from the Society for Endocrinology. "We provide evidence that in severely obese people, the levels of specific genes that control how fat is burned and stored in the body are changed to reflect poor metabolic health," says Professor Juleen Zierath, senior author of the study. Zierath continues, "After surgery, the levels of these genes are restored to a healthy state, which mirrors weight loss and coincides with overall improvement in metabolism."

A deeper investigation into the results of the study found that weight loss after surgery actually caused changes at a genetic level, leading to modifications among the DNA that control gene expression in response to the environment. In particular, chemical markings on two genes that control glucose and fat metabolism correlated with obesity are reversed after surgery-induced weight loss. Scientists are already suggesting that the findings may be useful for the design of new drugs that mimic the weight-loss-associated control of gene regulation. For the medical professionals at Dr. Feiz and Associates, this is exciting news.

Having graduated with Highest Honors from UCLA with a Bachelor's of Science degree in Neuroscience while simultaneously conducting research towards a Master's thesis in Biochemistry, Dr. Feiz had a thorough science background before becoming one of the most sought after surgeons for weight loss. Thus, it should come as no surprise that Dr. Feiz is always committed to remaining at the cusp of scientific discovery; bringing state-of-the-art tools and expert knowledge to every patient he treats.

For severely overweight or obese individuals, the results of the recent study provide a particularly compelling argument for seeking treatment from Dr. Feiz. For every prospective patient, Dr. Feiz and Associates provides a free consultation with a specialist who will address any patient concerns, and together, decide upon the ideal course of action for ensuring safe, rapid weight loss and long term health. For further information, please visit Dr. Feiz's website at www.drfeiz.com or call 800-868-5946 for your free initial consultation.

Release submitted by www.cyberset.com

SOURCE Dr. Feiz & Associates

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.